-
-
[1] Inzucchi SE, Bergenstal RM, Buse JB, et al.Management of hyperglycemia in type 2 diabetes:a patient-centered approach-position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)[J]. Diabetes Care, 2012, 35:1364-1379. doi: 10.2337/dc12-0413 [2] 陈卓, 张庆文. DPP-4抑制剂研究进展[J].上海医药, 2013, 34:50-54. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=shyy201307018 [3] Kirkman MS, Briscoe VJ, Clark N, et al. Diabetes in older adults[J]. Diabetes Care, 2012, 35:2650-2664. doi: 10.2337/dc12-1801 [4] 邢颖, 郑策, 甄健存.二肽基肽酶DPP-4抑制剂-西格列汀治疗2型糖尿病的安全性国内外文献分析[J].中国医院药学杂志, 2012, 32:480-481. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgyyyx201206028 [5] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2010年版)[J].中国糖尿病杂志, 2012, 20:S1-S36. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgtnbzz201201026
点击查看大图
计量
- 文章访问数: 143
- HTML全文浏览量: 34
- PDF下载量: 2
- 被引次数: 0